Murine Innate Immune Response to Virulent Toxigenic and NontoxigenicBacillus anthracisStrains
- 1 April 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (4), 1757-1764
- https://doi.org/10.1128/iai.01712-06
Abstract
Effective treatment of anthrax is hampered by our limited understanding of the pathophysiology of Bacillus anthracis infection. We used a genetically complete (pXO1(+) pXO2(+)) virulent B. anthracis strain and four isogenic toxin-null mutants to determine the effects of the anthrax edema toxin (ET; edema factor [EF] plus protective antigen [PA]) and lethal toxin (LT; lethal factor [LF] plus PA) on the host innate response during systemic infection. Using the spleen as an indicator for host response, we found that intravenous inoculation of LT-deficient mutants into C57BL/6 mice significantly increased production of several cytokines over that observed after infection with the parent strain or an EF-deficient mutant. Bacteria producing one or both of the toxins were capable of inducing significant apoptosis of cells present in spleens, whereas apoptosis was greatly reduced in mice infected with nontoxigenic mutants. Mice infected with toxin-producing strains also showed increased splenic neutrophil recruitment compared to mice infected with nontoxigenic strains and neutrophil depletion prior to infection with toxin-producing strains, leading to decreased levels of apoptosis. Together, these studies indicate that anthrax LT suppresses cytokine secretion during infection, but both EF and LF play roles in inducing neutrophil recruitment and enhancing apoptosis. Interestingly, in the absence of LF the effect of EF-induced cell recruitment is further enhanced, perhaps because LF so effectively suppresses the secretion of chemokines.Keywords
This publication has 50 references indexed in Scilit:
- Toxin-Deficient Mutants of Bacillus anthracis Are Lethal in a Murine Model for Pulmonary AnthraxInfection and Immunity, 2006
- Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In VivoInfection and Immunity, 2005
- Molecular basis for improved anthrax vaccinesAdvanced Drug Delivery Reviews, 2005
- Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxinCellular Microbiology, 2004
- New insights into the molecular mechanism of interleukin-10-mediated immunosuppressionJournal of Leukocyte Biology, 2004
- Macrophages Release Tumor Necrosis Factor Alpha and Interleukin-12 in Response to Intracellular Bacillus anthracis SporesInfection and Immunity, 2004
- Global Effects of Virulence Gene Regulators in aBacillus anthracisStrain with Both Virulence PlasmidsInfection and Immunity, 2003
- Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFαFEBS Letters, 1999
- Anthrax Lethal Factor Cleaves the N-Terminus of MAPKKs and Induces Tyrosine/Threonine Phosphorylation of MAPKs in Cultured MacrophagesBiochemical and Biophysical Research Communications, 1998
- Granulocyte apoptosis and the control of inflammationPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1994